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Most Plasmodium falciparum-infected children with cerebral malaria (CM) die from
respiratory arrest, but the underlying pathology is unclear. Here we present a model in
which the ultimate cause of death from CM is severe intracranial hypertension. Dynamic
imaging of mice infected with P. berghei ANKA, an accepted model for experimental CM,
revealed that leukocyte adhesion impairs the venous blood flow by reducing the functional
lumen of postcapillary venules (PCV). The resulting increase in intracranial pressure
(ICP) exacerbates cerebral edema formation, a hallmark of both murine and pediatric
CM. We propose that two entirely different pathogenetic mechanisms—cytoadherence
of P. falciparum-infected erythrocytes in pediatric CM and leukocyte arrest in murine
CM—result in the same pathological outcome: a severe increase in ICP leading to
brainstem herniation and death from respiratory arrest. The intracranial hypertension
(IH) model unifies previous hypotheses, applies to human and experimental CM alike,
eliminates the need to explain any selective recognition mechanism Plasmodium might
use to target multiple sensitive sites in the brain, and explains how an intravascular
parasite can cause so much neuronal dysfunction.
Keywords: Plasmodium, cytoadherence, postcapillary venule, intracranial hypertension, brain edema, CD8+ T cell,
macrophage, vascular leakage
PERSPECTIVE
Most pediatric cerebral malaria (CM) patients die from respi-
ratory arrest (Waller et al., 1991; Newton et al., 1997), but the
underlying pathology is unclear. One suggestion has been that
P. falciparum causes injury to a sensitive location such as the
brainstem, where a small lesion could have fatal consequences
(Haldar et al., 2007). Alternatively, death may require a combi-
nation of predisposing factors, thus explaining the relatively low
mortality rate (WHO, 2011). Here, we discuss insights gained
from P. berghei ANKA (PbA) infected mice, an accepted model
for experimental cerebral malaria (ECM), in the context of recent
advances in the understanding of the pathogenesis of human cere-
bral malaria (HCM). For the purpose of this Perspective, we focus
on pediatric HCM, because African children with HCM tend to
exhibit more BBB dysfunction, monocyte and platelet accumula-
tion in the brain, and intracranial hypertension (IH) compared
to adult HCM patients in Southeast Asia (Hawkes et al., 2013).
Pediatric HCM therefore resembles more closely themurine ECM
model in terms of clinical features, autopsy findings, and cerebral
edema formation.
HYPOTHESES FOR CM PATHOGENESIS
The mechanism by which P. falciparum infected red blood cells
(iRBC) cause death is not completely understood. Several models
have been proposed over the decades to explain the pathogenesis
of HCM (Table 1). (1) Extending Frerichs’ original obstruc-
tion hypothesis (Frerichs, 1858), Laveran attributed neurological
symptoms and coma to parasites obstructing cerebral capillar-
ies (Laveran, 1884). (2) Marchiafava and Bignami’s sequestration
hypothesis postulates that severe malaria is caused by iRBC accu-
mulating toward the circumference of larger vessels thereby stop-
ping or retarding blood circulation (Marchiafava and Bignami,
1894). In fatal cases of HCM, large numbers of iRBC plug cap-
illaries and reduce their functional lumen (Macpherson et al.,
1985). (3) Maegraith’s inflammation hypothesis proposes that the
parasite, whether cytoadherent or not, initiates a chain reaction
that allows protein and water to escape through the dysfunctional
endothelium, eventually leading to irreversible inflammatory
obstruction of the blood flow (Maegraith, 1974). (4) The cytokine
hypothesis likens HCM to an encephalopathy, in which patholog-
ical changes such as edema and coma are of inflammatory origin
(Clark and Rockett, 1994). (5) A combined sequestration and vas-
cular inflammation model (Grau and De Kossodo, 1994; Hermsen
et al., 1997; Postels et al., 2013) holds that endothelial upregula-
tion of adhesionmolecules causes iRBC cytoadherence to platelets
and leukocyte arrest thereby intensifying endothelial activation
and promoting further iRBC sequestration; endothelial death is
thought to eventually cause irreversible blood brain barrier (BBB)
damage in the absence of vascular occlusion. (6) The tissue factor
model (Francischetti, 2008) encompasses a series of ordered steps
for disease progression with iRBC sequestration as crucial initial
event triggering endothelial activation and tissue factor expres-
sion thus initiating a cascade of coagulation and inflammation;
sequestration of iRBC and platelets then amplifies this cascade
resulting in disseminated intravascular coagulation contribut-
ing to multi-organ dysfunction and failure. (7) In the PfEMP1
CIDRα1/EPCR model, severe pediatric disease is mediated by
UpsA var genes (DC 8 and 13) expressing iRBC that bind to
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the endothelial protein C receptor (EPCR) (Moxon et al., 2013;
Turner et al., 2013). This interaction inhibits the cytoprotec-
tive and anti-inflammatory signaling cascade induced by binding
and activation of protein C to EPCR resulting in the activa-
tion of protease activated receptor 1 (PAR1) which can trigger
a proinflammatory cascade and decrease barrier stability (Xue
et al., 2010). Thus, many factors contribute to HCM pathogene-
sis and this complexity helps explain the apparently contradictory
hypotheses proposed over the past century (Van Der Heyde et al.,
2006; Idro et al., 2010b). Here, we discuss another model in
which the ultimate cause of death from pediatric CM is severe IH.
Our model combines prior hypotheses and applies to both ECM
and HCM, in particular in pediatric patients with a primarily
neurological syndrome (Idro et al., 2010b).
LESSONS FROM THE MURINE MODEL
Because it is nearly impossible to explore cellular events associ-
ated with the collapse of the BBB in HCM patients, we used the
PbA-infected CBA/CaJ mouse model to monitor the dynamics of
various leukocyte subpopulations within the cortical microvascu-
lature and attempted to correlate our findings with what is known
about HCM. In summary, our studies support the hypothesis
that ECM-associated pathology is caused by a severe restriction in
the venous blood flow due to steric hindrance by arrested leuko-
cytes, not iRBCs, resulting in IH. Using intravital microscopy
(IVM), we found more platelets, CD8+ T cells, neutrophils,
and macrophages accumulated in postcapillary venules (PCV)
from PbA-infected mice with ECM compared to P. yoelii XL
(PyXL)-infected mice, which develop hyperparasitemia without
neurological signs (Nacer et al., 2012, in press). In mice with
symptomatic ECM, leukocyte adhesion reduced the functional
vascular cross-section of PCV and larger venules significantly
and this can explain the reduced cerebral blood flow observed
by MRI (Kennan et al., 2005). Supporting our findings, nitric
oxide, a key messenger involved in regulation of platelet adhe-
sion and inflammatory and immune responses (Willenborg et al.,
2007), decreased both leukocyte accumulation and vascular resis-
tance in venules of PbA-infected mice (Cabrales et al., 2011;
Hawkes et al., 2011). Neither capillaries nor arterioles in the cor-
tical microvasculature of mice with ECM nor PCV, arterioles, or
capillaries of mice with hyperparasitemia were affected (Nacer
et al., in press), thus emphasizing the central role of the post-
capillary venule BBB in the ECM-associated vasculopathy (Nacer
et al., 2012). Similarly, CD8+ T cells were observed to actively
crawl along the wall of larger vessels of the olfactory bulb of
PbA-infected mice (Zhao et al., 2014). Because leukocyte adhe-
sion occurred in PCV and larger venules, the center of these
vessels remained perfused and complete vascular occlusion was
not observed. However, the severe restriction in the venous blood
efflux from the brain likely exacerbates edema formation, a hall-
mark of both ECM and HCM (Sanni, 2001; Penet et al., 2005;
Medana and Turner, 2006). Brains from mice with ECM, not
hyperparasitemia, have a soft and spongy texture and bulge out
of the skull when the dura is accidentally damaged during surgery
(Nacer et al., in press). Furthermore, MRI data obtained in mice
with ECM provide clear evidence for edema formation, compres-
sion of the cerebellum, as well as enlargement and compaction
of the brainstem into foramen magnum, all changes compatible
with death from IH (Penet et al., 2005).
Arteriolar vasospasms during ECM (Cabrales et al., 2010), due
to either increased production of vasoconstrictive mediators or
inhibition of vasodilating factors (Martins and Daniel-Ribeiro,
2013) have also been proposed to be important for ECM patho-
genesis. Recently, endothelin-1 (ET-1), a vasoactive peptide with
inflammatory and platelet-activating properties (Freeman et al.,
2014), was shown to be upregulated during both ECM and HCM
(Basilico et al., 2002; Dai et al., 2012). C57BL/6 mice displayed
neurological signs following the administration of exogenous
ET-1 upon infection with PbNK65, a strain that normally does
not induce ECM in these mice (Nacer et al., 2012; Martins et al.,
2014). Conversely, ECM development was prevented by inhibi-
tion of the ET-1 receptor A (Dai et al., 2012). Based on these
data, a major role for arteriolar vasoconstriction was proposed
for ECM induction in the C57BL/6 mouse model (Freeman et al.,
2014). However, ET-1 has a plasma-half life of less than a minute
in rodents and it also stimulates the upregulation of endothelial
adhesion molecules, promotes leukocyte adhesion, and increases
vascular permeability (Callera et al., 2003; King-Vanvlack et al.,
2003). Therefore, ET-1 may in fact induce IH (and/or ECM) by
restricting the venous blood flow via leukocyte adhesion, pre-
venting adequate brain perfusion via vasoconstriction (Yuh and
Dillon, 2010), and inducing BBB disruption. Together, these con-
siderations suggest that a combination of impaired venous efflux
and reduced cerebral perfusion causes death from ECM.
SEQUENCE OF EVENTS
Cytoadherence of P. falciparum expressing a PfEMP1 with a
tropism for EPCR increases barrier permeability by interfer-
ing with the activation of cytoprotective and anti-inflammatory
pathways, eventually culminating in severe childhood malaria
(Smith et al., 2013; Turner et al., 2013). Similarly, vascular leakage
became apparent 1 day before ECMdevelopment, while leukocyte
arrest intensified only after the onset of neurological signs (Nacer
et al., 2012, in press). Further, PbA-infected mice were shown
to exhibit a cytokine storm 24 h prior to the onset of neurolog-
ical signs with upregulation of a number of cytokines including
IL-6, IL-10, and RANTES (Zhao et al., 2014). Thus, it appears
that tight junction loosening is independent of iRBC cytoad-
herence and that vascular leakage precedes leukocyte arrest. In
support of this notion, (1) traumatic brain injury is character-
ized by initial BBB disruption, followed by ICAM-1 upregulation
and recruitment of neutrophils, macrophages, platelets, CD8+
and CD4+ T cells (Shlosberg et al., 2010); (2) experimental BBB
disruption induces transcriptional changes leading to upregula-
tion of NF-κB, Stat3, IL-6, CD14, and complement (Cacheaux
et al., 2009), events that are frequently associated with severe
malaria (Day et al., 1999; Angulo and Fresno, 2002; Tripathi et al.,
2009; Higgins et al., 2011; Liu et al., 2012; Noone et al., 2013);
and (3) TNF-α, a cytokine with barrier permeability increas-
ing capabilities (Tsao et al., 2001) that has also been linked to
BBB disruption in various hepatic encephalopathies (Cui et al.,
2013), is involved in the pathogenesis of both ECM and HCM
(Hunt et al., 2006) together with several other members of the
TNF superfamily (Randall et al., 2010). Together, these findings
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suggest that leukocyte accumulation coincides with the final
phase of CM.
INTRACRANIAL HYPERTENSION IN HCM
Over two decades ago, Newton and colleagues associated
increased intracranial pressure (ICP) with poor outcomes in pedi-
atric HCM patients in Kenya (Newton et al., 1991). Severe IH
is difficult to diagnose based on clinical signs. The most reliable
clinical indicator for ICP spikes has been pupil dilation with slug-
gish or absent responses to light (Newton et al., 1997). Using an
invasive monitor to measure the opening pressure during lum-
bar puncture, two studies in Kenyan and Gambian children with
HCM documented a correlation between increased ICP and poor
prognosis, i.e., coma and death, or severe neurological sequelae in
survivors (Waller et al., 1991). A more recent Kenyan study con-
firmed the close correlation between HCM and increased ICP in
pediatric HCM, but also showed that repeated lumbar opening
pressure measurements are required to reveal the maximum ICP
or the temporal relationship between ICP and seizures or agonal
events (Beare et al., 2012).
Transcranial Doppler is now increasingly being used as an
important non-invasive tool in neurocritical care to estimate ICP
and cerebral perfusion pressure (Saqqur et al., 2007). IH forces
the CSF into the perineural space between the dura mater and the
optic nerve causing the optic nerve sheath (ONS) to swell. ONS
diameters can be measured by ultrasonography and increases in
diameter correlate with IH (Le et al., 2009). Ultrasonography
is feasible even in low-resource settings where most pediatric
HCM patients are treated. In Malawi, bedside hand-held devices
revealed increased ONS diameters in all children diagnosed with
HCM (Murphy et al., 2011). In Uganda, neurological sequelae
were significantly more common in children with increased ONS
diameter, although fatalities were similar in children with and
without increased ONS diameter (Murphy et al., 2011; Beare
et al., 2012). These findings prompt questions. Are vascular alter-
ations observed by retinoscopy such a good predictor of fatal
HCM, because ONS swelling impairs perfusion of the retinal vein
at the optic canal—similar to compression of the brainstem? How
reversible are vascular injuries in the retina if the child survives
and do they occur in patients who never enter the agonal phase of
the disease?
IH-mediated compression of respiration centers in medulla
and pons can explain why many children die from respiratory
arrest despite adequate pulse and blood pressure (Waller et al.,
1991; Newton et al., 1997). Indeed, comparison of MRI and
autopsy data from pediatric patients recently identified brainstem
herniation due to increased brain volume as the strongest predic-
tor of death HCM (Seydel et al., 2011; Kampondeni et al., 2013).
In addition, mechanical vascular injury due to stretching during
caudal displacement of the brainstem through the foramen mag-
num explains the marked hemorrhaging associated with HCM
(Yuh and Dillon, 2010). Together, these data suggest a direct link
between IH and fatal HCM.
NEUROLOGICAL SYMPTOMS AND SEQUELAE
Differences in duration and intensity of IH can explain the vari-
ability in severity of neurological sequelae in HCM survivors
(Idro et al., 2010b). IH, repeated and prolonged seizures, as
well as deep and prolonged coma are known risk factors for
poor outcome predominantly in pediatric HCM (Van Hensbroek
et al., 1997; Idro et al., 2006), but how these factors lead to
IH and neural injury is unknown (Idro et al., 2010a; Beare
et al., 2012). Global compression and hypoperfusion of the brain
due to edema and general swelling offers an explanation for
the cognitive deficits, behavioral difficulties and neuropsychiatric
sequelae suffered by many HCM survivors. Analogous to brain-
stem herniation through the foramen magnum and its effect
on respiration (Kampondeni et al., 2013), herniation into other
foramina of the skull could compress the olfactory, optic, vestibu-
locochlear, glossopharyngeal, and hypoglosseal nerves as well as
the accompanying blood vessels. Resulting damage can explain,
at least in part, other major long-term sequelae such as deficits
in vision, hearing, and smell. The notion that IH can be caused
by sequestration of iRBC as well as leukocytes is supported by
reports documenting that both HCM and ECM are associated
with deafness, loss of smell, and blindness (Brewster et al., 1990;
Schmutzhard et al., 2010, 2011; Idro et al., 2010a; Saggu et al.,
2011; Zhao and Mackenzie, 2011; Zhao et al., 2014). Thus, IH
eliminates the need to explain any selective recognition mech-
anism Plasmodium might use to target multiple sensitive sites
in the brain (Idro et al., 2010b). Further, leukocyte sequestra-
tion likely also plays a role in IH during P. falciparum HCM,
because artesunate treatment did not rescue patients with a low
sequestered parasite biomass (White et al., 2013) and also had a
higher efficacy in predominantly adult Asian patients compared
to African children, who exhibit significantly more mononuclear
cell sequestration (Silamut et al., 1999; Dorovini-Zis et al., 2011),
particularly the CM2 group (Milner et al., 2013). Thus, human
and murine CM induce very similar neurological symptoms and
signs, respectively, including non-life-threatening neurological
impairments.
The CM-associated pathology is similar to that found in other
IH-driven neurological disorders. In idiopathic IH, for exam-
ple, impaired venous outflow from the brain can cause headache,
nausea, vomiting, and altered consciousness, including stupor or
coma in severe cases (Yuh and Dillon, 2010). Other symptoms
include pulsatile tinnitus and visual alterations up to blindness
due to swelling of the optic disc. As for HCM, the essential diag-
nostic criterion is an increased lumbar puncture opening pressure
(Yuh and Dillon, 2010) and the central retinal vein pressure is
used as surrogate for ICPmeasurement (Harder et al., 2007; Jonas
et al., 2008). Occasionally, idiopathic IH can lead to tonsillar
herniation, brainstem compression, and death (Yuh and Dillon,
2010).
THE INTRACRANIAL HYPERTENSION MODEL
Based on these considerations, we propose that two entirely dif-
ferent pathogenetic mechanisms—cytoadherence of P. falciparum
iRBC in pediatric HCM and leukocyte arrest in ECM—drive a
severe restriction in the venous blood flow that results in the
same pathophysiological outcome: IH (Figure 1). In HCM, the
primary function of sequestration of P. falciparum iRBC is con-
sidered to be an immune evasion mechanism allowing parasites
to avoid splenic clearance (Safeukui et al., 2008; Buffet et al.,
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FIGURE 1 | Pathogenesis of human and murine cerebral
malaria—proposed sequence of events. The intracranial
hypertension hypothesis explains how two entirely different
pathogenetic mechanisms—cytoadherence of P. falciparum-infected
erythrocytes in pediatric CM and leukocyte arrest in murine
CM—can result in the same pathological outcome: a severe
increase in intracranial pressure leading to brainstem herniation and
death from respiratory arrest.
2009). P. falciparum iRBC sequestration is known to occur in all
organs, not only the brain. Therefore, upregulation of adhesion
molecules, at any site, would increase sequestration and disrupt
the venous blood flow. However, enclosure into the skull allows
little room for expansion, rendering the brain especially prone
to serious damage. Regarding ECM, PbA infection causes the
recruitment of larger numbers of activated leukocytes compared
to infection with PyXL (Nacer et al., 2012, in press). Leukocyte
accumulation, like iRBC sequestration, reduces the venous efflux
and raises the ICP, in severe cases potentially leading to brainstem
compression and respiratory arrest. The IH model unifies previ-
ous hypotheses, applies to the pathogenesis of HCM and ECM
alike, and explains how a largely intravascular parasite can cause
so much neuronal dysfunction, even in the absence of cytoadher-
ence, andwhy anti-malarial treatment can reverse coma so rapidly
and without significant tissue necrosis despite large numbers of
iRBC in the brain of most patients. Further, variations in sever-
ity and/or duration of IH can explain why some children have
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a poor neurological outcome, while others improve rapidly with
minimal deficits despite similar clinical presentation.
Thus, despite fundamental differences in parasite biology,
the PbA-infected mouse model is suitable for study of blood
flow alterations in the human brain that are not readily acces-
sible in P. falciparum-infected individuals. Perhaps more rele-
vant, the leukocyte arrest-induced venous blood flow impairment
can also explain the increasingly reported severe complications
in monoinfections in P. vivax, an essentially non-cytoadherent
Plasmodium species, which tend to take a similar course as P. fal-
ciparum infections (Beg et al., 2002; Sharma et al., 2012; Sarkar
et al., 2013; Goyal and Makwana, 2014). The shared predilec-
tion for reticulocyte invasion (McNally et al., 1992; Cromer et al.,
2006; Panichakul et al., 2007; Russell et al., 2011), the marked
proinflammatory responses, and the reversible microvascular
dysfunction typically associated with P. vivax infections (Thapa
et al., 2007; Andrade et al., 2010) all suggest that the PbA-infected
mouse model is also suitable for study of the pathogenesis of
severe P. vivax malaria, including HCM. The PbA-mouse ECM
model can reveal reversible agonal events obscured in autopsy
material and allows in vivomonitoring techniques such as IVMon
the microscopic and MRI on the macroscopic level that can help
identify the ultimate cause of death fromHCM. Clinical efforts to
maintain normal ICP and cerebral perfusion and to avoid factors
that exacerbate IH, as recommended for treatment of idiopathic
IH, may also help patients survive the critical phase of HCM with
minimal neurological sequelae. When resources allow, perhaps
decompressive craniotomy, a successful strategy in idiopathic IH
patients, could save the lives of children living in P. falciparum
endemic areas.
CONCLUSIONS AND FUTURE DIRECTIONS
In agreement with Marchiafava’s and Bignami’s hypothesis that
iRBC sequestration retards the blood flow in larger veins during
the agonal period of severe malaria (Marchiafava and Bignami,
1894), we argue that venous blood flow impairment is suffi-
cient to increase the ICP to a point that the resulting cerebral
edema leads to brainstem herniation and death from respira-
tory arrest. Simultaneous venous efflux restriction and continued
influx of arterial blood necessarily exacerbates vascular injury
and promotes hemorrhaging. Because the majority of success-
fully treated comatose HCM patients recover without perma-
nent neurological deficits (Brewster et al., 1990; White and Ho,
1992; Idro et al., 2010b), many of the pathological alterations
detected in autopsy specimens may not adequately reflect the
cerebral blood perfusion before death. Further, iRBC seques-
tration in larger vessels allows continued perfusion so that
distinction between capillaries and PCV is crucial to evaluate
blood flow obstruction prior to the agonal phase of the dis-
ease. Because size and morphology suggest that most of the
published blood vessels with cytoadherent P. falciparum iRBC
are PCV and because the blood flow in murine PCV contin-
ues despite leukocyte arrest, we propose that the contribution
of vascular occlusion to HCM pathogenesis is less important
than frequently assumed. Longitudinal ICP measurements, MRI-
based monitoring of the brain, IVM, and—once available—high-
resolution imaging of the retinal microvasculature, in patients or
murine models, are expected to reveal the ultimate cause of death
from CM.
OF MICE AND MEN
We hope to have conveyed to the reader that there is value to
the ECM PbA model even without it strictly replicating obser-
vations in human disease caused by P. falciparum. For example,
in our view, P. berghei has not been conclusively shown to cytoad-
here in vivo or sequester within infected mice. Our contention is
that another mechanism, leukocyte adhesion, produces the same
end point. Sadly, in order to make this model acceptable, paral-
lels with P. falciparum HCM are sought where none exist. Even
more so, because the focus on the unique aspects of P. falci-
parum infection, cytoadhesion and sequestration, may distract
from pathogenic mechanisms that may be equally important,
for example for complicated P. vivax infections. Many labs have
attempted to demonstrate P. vivax iRBC cytoadhesion in order to
justify the occurrence of clinical CM in patients infected with this
parasite. This is tragic because the presence of all parasite stages
in the blood suggests that P. vivax is essentially non-cytoadherent.
Thus, iRBC sequestration is no longer sufficient to explain the
pathogenesis of CM.
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